Zdrowie i gospodarka · 05/10/2023
FDA Announces Draft Guidance for Developing Stimulant Use Disorder Treatments
The FDA is releasing a draft guidance to help pharmaceutical companies develop effective treatments for moderate to severe cocaine, methamphetamine, and prescription stimulant use disorders.
Source: Federal Register — Food and Drug AdministrationOpen original release →